Global Retirement Partners’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $505K | Buy |
+2,225
| New | +$396K | 0.01% | 1028 |
|
|
2025
Q4 | $375K | Buy |
1,882
+1,828
| +3,385% | +$332K | 0.01% | 1117 |
|
|
2025
Q3 | $8.45K | Hold |
54
| – | – | ﹤0.01% | 2762 |
|
|
2025
Q2 | $8.19K | Buy |
+54
| New | +$7.2K | ﹤0.01% | 2701 |
|
|
2024
Q4 | $4.8K | Buy |
26
+7
| +37% | +$1.35K | ﹤0.01% | 2701 |
|
|
2024
Q3 | $3.74K | Sell |
19
-3
| -14% | -$623 | ﹤0.01% | 2693 |
|
|
2024
Q2 | $4.54K | Sell |
22
-6
| -21% | -$1.36K | ﹤0.01% | 2658 |
|
|
2024
Q1 | $7.59K | Hold |
28
| – | – | ﹤0.01% | 2233 |
|
|
2023
Q4 | $5.78K | Buy |
28
+6
| +27% | +$1.18K | ﹤0.01% | 2271 |
|
|
2023
Q3 | $4.2K | Sell |
22
-3
| -12% | -$616 | ﹤0.01% | 2252 |
|
|
2023
Q2 | $5.26K | Sell |
25
-1
| -4% | -$199 | ﹤0.01% | 2180 |
|
|
2023
Q1 | $4.98K | Sell |
26
-72
| -73% | -$16.3K | ﹤0.01% | 2166 |
|
|
2022
Q4 | $21.4K | Sell |
98
-5
| -5% | -$1.09K | ﹤0.01% | 1453 |
|
|
2022
Q3 | $22K | Buy |
103
+6
| +6% | +$1.29K | ﹤0.01% | 1348 |
|
|
2022
Q2 | $21K | Sell |
97
-6
| -6% | -$1.47K | ﹤0.01% | 1337 |
|
|
2022
Q1 | $23K | Buy |
+103
| New | +$31.8K | ﹤0.01% | 1301 |
|
|
2021
Q4 | – | Sell |
-52
| Closed | -$21K | – | 533 |
|
|
2021
Q3 | $21K | Buy |
52
+34
| +189% | +$14.1K | ﹤0.01% | 1184 |
|
|
2021
Q2 | $7K | Buy |
18
+13
| +260% | +$4.34K | ﹤0.01% | 1471 |
|
|
2021
Q1 | $1K | Sell |
5
-24
| -83% | -$6.67K | ﹤0.01% | 1701 |
|
|
2020
Q4 | $7K | Buy |
29
+3
| +12% | +$714 | ﹤0.01% | 1350 |
|
|
2020
Q3 | $6K | Hold |
26
| – | – | ﹤0.01% | 1272 |
|
|
2020
Q2 | $5K | Sell |
26
-8
| -24% | -$1.28K | ﹤0.01% | 1285 |
|
|
2020
Q1 | $4K | Hold |
34
| – | – | ﹤0.01% | 1267 |
|
|
2019
Q4 | $5K | Sell |
34
-7
| -17% | -$969 | ﹤0.01% | 1325 |
|
|
2019
Q3 | $5K | Buy |
41
+1
| +3% | +$134 | ﹤0.01% | 1288 |
|
|
2019
Q2 | $6K | Sell |
40
-27
| -40% | -$3.66K | ﹤0.01% | 1234 |
|
|
2019
Q1 | $10K | Sell |
67
-4
| -6% | -$526 | ﹤0.01% | 1049 |
|
|
2018
Q4 | $8K | Sell |
71
-77
| -52% | -$9.64K | ﹤0.01% | 1028 |
|
|
2018
Q3 | $20K | Hold |
148
| – | – | ﹤0.01% | 802 |
|
|
2018
Q2 | $17K | Buy |
148
+61
| +70% | +$6.59K | ﹤0.01% | 842 |
|
|
2018
Q1 | $9K | Hold |
87
| – | – | ﹤0.01% | 986 |
|
|
2017
Q4 | $10K | Sell |
87
-7
| -7% | -$762 | ﹤0.01% | 897 |
|
|
2017
Q3 | $10K | Sell |
94
-1
| -1% | -$103 | ﹤0.01% | 826 |
|
|
2017
Q2 | $10K | Hold |
95
| – | – | ﹤0.01% | 778 |
|
|
2017
Q1 | $9K | Hold |
95
| – | – | 0.01% | 766 |
|
|
2016
Q4 | $7K | Buy |
+95
| New | +$7.21K | ﹤0.01% | 766 |
|
Other funds holding CRL
AI
Global Retirement Partners's CRL Position: Q2 2026 in Review
Global Retirement Partners opened a new position in Charles River Laboratories (CRL) in Q2 2026: 2,225 shares worth $505K. The stake represents 0.01% of the portfolio and ranks #1028 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in CRL as recently as Q4 2025.
Global Retirement Partners first reported a position in CRL in Q4 2016 and has held it in 36 quarters since. 569 funds tracked by Wall St. Rank hold CRL as of Q2 2026.
- Global Retirement Partners held 2,225 shares of Charles River Laboratories worth $505K as of Q2 2026.
- Charles River Laboratories was a new Global Retirement Partners position in Q2 2026.
- Charles River Laboratories made up 0.01% of Global Retirement Partners's portfolio in Q2 2026, its #1028 holding.
- Global Retirement Partners first reported a position in Charles River Laboratories in Q4 2016 and has held it in 36 quarters since.
- 569 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.
Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.